ScreenerHero

VXLVaxil Bio Ltd.

TSXV · CA · Healthcare · Biotechnology
0.1600CAD0.00%Mkt Cap: 464225 $P/E: 0.89

Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. The company is headquartered in Toronto, Canada.

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap464.22K $
Enterprise Value80.43K $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)380.15K $
Revenue/Share—
Last Price0.1600 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.89
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.51
EPS (TTM)0.18
EPS (Forward)—
52W Range
0.130019% of range0.2900
52W High0.2900 CAD
52W Low0.1300 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE38.24%
ROA38.10%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-115.07K $
CapEx (TTM)—
FCF Margin—
FCF Yield9.61%
Net Debt-383.79K $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio16.92
Quick Ratio16.92
Book Value/Sh0.3160 CAD
Cash/Share0.1320 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMay 15, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.98M
Float3.76M
Insiders5.61%
Institutions0.00%
Short Interest
Short Ratio0.5d
Short % Out.0.00%
Shares Short573
Short (prev mo.)1.00K
Technical
SMA 500.1708 (-6.3%)
SMA 2000.1688 (-5.2%)
Beta-0.88
S&P 52W Chg18.16%
Avg Vol (30d)840
Avg Vol (10d)220
Technical Indicators
RSI (14)29.3
MACD-0.0039
MACD Signal-0.0039
MACD Hist.-0.0000
BB Upper0.1852 CAD
BB Middle0.1673 CAD
BB Lower0.1493 CAD
BB Width21.42%
ATR (14)0.0023 CAD
Vol Ratio (20d)0.00x